Home

EASTBOURNE CAPITAL MANAGEMENT LLC/CA

CIK 1140888 · last filed 2010-05-12

EASTBOURNE CAPITAL MANAGEMENT LLC/CA is a corporate insider who has filed 41 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for TELK, was dated May 12, 2010. Across all open-market trades the lifetime net is −$212.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $431.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$431.50M

Companies

5

Total Filings

41

Lifetime Open-Market Net

-$212.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted 10%+ Owner 1,696,646 — — -$6.02M 13 2010-05-12
Sarepta Therapeutics, Inc. (AVII) Delisted 10%+ Owner 943,202 — — -$5.55M 2 2010-03-08
CASSAVA SCIENCES INC (PTIE) Delisted 10%+ Owner 3,265,627 — — -$33.56M 9 2009-09-29
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted 10%+ Owner 15,919,863 — — -$95.50M 15 2009-09-18
MTG 10%+ Owner 14,900,000 $28.96 $431.50M -$71.50M 2 2009-09-16

Recent Filings

41 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2010-05-12 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Other (J) −10,317,291 $0 EDGAR
2010-03-08 Sarepta Therapeutics, Inc. (AVII) Delisted Sell (S) −4,094,646 -$5.08M EDGAR
2009-11-13 Sarepta Therapeutics, Inc. (AVII) Delisted Sell (S) −333,950 -$473.1K EDGAR
2009-09-30 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Sell (S) −404,000 -$333.3K EDGAR
2009-09-29 CASSAVA SCIENCES INC (PTIE) Delisted Sell (S) −3,076,915 -$15.31M EDGAR
2009-09-23 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Sell (S) −1,075,191 -$952.2K EDGAR
2009-09-18 MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted Sell (S) −145,809 -$174.1K EDGAR
2009-09-18 AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Sell (S) −3,853,880 -$54.21M EDGAR
2009-09-16 MTG Sell (S) −8,200,245 -$74.12M EDGAR
2009-08-11 CASSAVA SCIENCES INC (PTIE) Delisted Sell (S) −1,663,000 -$6.59M EDGAR
Showing 1–10 of 41
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.